Detalhe da pesquisa
1.
Cured or Not? Long-term Outcomes of Immunotherapy Responders. Focus on Melanoma.
Curr Oncol Rep
; 25(9): 989-996, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37266890
2.
eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies.
Nature
; 513(7516): 105-9, 2014 Sep 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-25079330
3.
Acute cholestatic hepatitis in a patient with metastatic melanoma.
J Hepatol
; 79(1): e13-e15, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37330752
4.
Invasive cutaneous infection due to Scopulariopsis brevicaulis unsuccessfully treated with high-dose micafungin in a neutropenic patient.
Infection
; 45(3): 361-363, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27909895
5.
Kidney injuries related to ipilimumab.
Invest New Drugs
; 32(4): 769-73, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24687600
6.
Impact of immunosuppressive agents on the management of immune-related adverse events of immune checkpoint blockers.
Eur J Cancer
; 204: 114065, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38643707
7.
Onset of connective tissue disease following anti-PD1/PD-L1 cancer immunotherapy.
Ann Rheum Dis
; 77(3): 468-470, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28242618
8.
Severe colitis in patients with melanoma treated with BRAF/MEK inhibitors.
Aliment Pharmacol Ther
; 57(7): 792-799, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36578099
9.
Phase I Study of Androgen Deprivation Therapy in Combination with Anti-PD-1 in Melanoma Patients Pretreated with Anti-PD-1.
Clin Cancer Res
; 29(5): 858-865, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36516188
10.
Protective effect of obesity on survival in cancers treated with immunotherapy vanishes when controlling for type of cancer, weight loss and reduced skeletal muscle.
Eur J Cancer
; 178: 49-59, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36403367
11.
Sarcoid-like Granulomatosis Associated with Immune Checkpoint Inhibitors in Melanoma.
Cancers (Basel)
; 14(12)2022 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35740604
12.
A PD-1/PD-L1 Proximity Assay as a Theranostic Marker for PD-1 Blockade in Patients with Metastatic Melanoma.
Clin Cancer Res
; 28(3): 518-525, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34785583
13.
Radiomics to evaluate interlesion heterogeneity and to predict lesion response and patient outcomes using a validated signature of CD8 cells in advanced melanoma patients treated with anti-PD1 immunotherapy.
J Immunother Cancer
; 10(10)2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36307149
14.
[Treatment of melanoma with immune checkpoints inhibitors]. / Traitement du mélanome par les inhibiteurs du contrôle immunitaire.
Rev Prat
; 71(4): 380-383, 2021 Apr.
Artigo
em Francês
| MEDLINE | ID: mdl-34161002
15.
Outcomes of patients with cancer and sarcoid-like granulomatosis associated with immune checkpoint inhibitors: A case-control study.
Eur J Cancer
; 156: 46-59, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34425404
16.
Positive Association Between Location of Melanoma, Ultraviolet Signature, Tumor Mutational Burden, and Response to Anti-PD-1 Therapy.
JCO Precis Oncol
; 52021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34950838
17.
A three-year-analysis of fixed drug eruptions in hospital settings in France.
Eur J Dermatol
; 20(4): 461-4, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20507840
18.
Melanoma Persister Cells Are Tolerant to BRAF/MEK Inhibitors via ACOX1-Mediated Fatty Acid Oxidation.
Cell Rep
; 33(8): 108421, 2020 11 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33238129
19.
Dose escalation phase 1 study of radiotherapy in combination with anti-cytotoxic-T-lymphocyte-associated antigen 4 monoclonal antibody ipilimumab in patients with metastatic melanoma.
J Immunother Cancer
; 8(2)2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32819972
20.
Fatal myasthenia gravis (MG) associated with myositis and myocarditis in a patient with pre-existing MG treated by adjuvant nivolumab for a stage III melanoma.
Eur J Cancer
; 205: 114098, 2024 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38761774